WHO WE ARE

The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.

 

NEWS FROM THE ECF

Public Release: English Translation of V2.00 of Japan EDC Management Sheet

Public Release: English Translation of V2.00 of Japan EDC Management Sheet

Japan Pharmaceuticals and Medical Devices Agency (PMDA) issued the first version of EDC Management Sheet in 2013 to ensure the computerized system used in clinical trials comply with the electronic records and electronic signatures guideline as well as the GCP regulations. This sheet is reviewed at the time of PMDA reviews and inspections.

You can download the original in Japanese from: https://www.pmda.go.jp/review-services/inspections/reexam-reeval/0005.html

Japan Pharmaceutical Manufacturers Association (JPMA), an organization representing the research-based pharmaceutical industry operating in Japan, volunteered to translate the EDC Management Sheet  V1.0 into English, and posted it on their website.  In July 2021, PMDA made minor changes and issued v2.00 of the EDC Management Sheet.  JPMA made clear they would not translate it this time.  The eClinical Forum thought it a good idea to translate it to contribute to the industry.  JPMA generously agreed for the eClinical Forum to build upon their v1.00 translation as a basis.  Also, JPMA requested to make it clear that JPMA was not involved in the v2.00 translation.

 

Documents to download

Print
Tags:
Rate this article:
No rating

NOT A MEMBER?

Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)
«March 2023»
MonTueWedThuFriSatSun
2728
eCF Webinar: Artificial intelligence can improve patients’ experience in decentralized clinical trials

eCF Webinar: Artificial intelligence can improve patients’ experience in decentralized clinical trials

The clinical trial industry is undergoing a rapid transition toward decentralization, where some or all health assessments are performed remotely in participants’ homes instead of in medical centers. Adopting artificial intelligence in this setting can empower more patients to enroll in trials, successfully complete them without burden, and submit high-fidelity assessments of their health. In this talk, the presenters will discuss insights from their recent article in Nature Medicine on this topic.  The article can be viewed at: Artificial intelligence can improve patients’ experience in decentralized clinical trials | Nature Medicine

Read more
12345
6789101112
13141516171819
20212223242526
272829303112
3456789

Upcoming events Events RSSiCalendar export